Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -9.22 | N/A |
| PEG Ratio (TTM) | -0.41 | N/A |
| P/S Ratio (TTM) | 1.03 | N/A |
| P/B Ratio (TTM) | 0.47 | N/A |
| P/FCF Ratio (TTM) | -5.76 | N/A |
| Price to 5YR AVG Earnings Ratio | 27.55 | N/A |
| Price to 5YR AVG FCF Ratio | -4.84 | N/A |
Profitability (3%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -2.86% | N/A |
| ROE (TTM) | -5.04% | N/A |
| Net Profit Margin (TTM) | -10.73% | N/A |
| ROIC 5YR AVG | 0.33% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.34% | 158.85% | 53.75% |
| Revenue | 9.11% | 13.31% | -0.73% |
| Net Income | 3.44% | 163.37% | 57.10% |
| Cash Flow | -267.26% | 27.78% | 11.39% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.13 | N/A |
| Quick Ratio (TTM) | 1.04 | N/A |
| D/E Ratio (TTM) | 0.27 | N/A |
| Interest Coverage (TTM) | -8.68 | N/A |
| Piotroski F-Score | 2 | N/A |
| Altman Z-Score | 1.00 | N/A |
| LTL to 5YR AVG FCF | -0.12 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.78% | N/A |